Equity Analysis /
United States of America

US : Biotechnology - Biotechnology | Caution Definitely Still Warranted for Gene Editing Approaches to Hemoglobinopathies

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    4 November 2021
    Published by